AnaptysBio Inc.
ANAB | NASDAQ
$47.49
-$0.79 (-1.64%)
Nov 2, 2026, 12:36 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -70.26 | -1.72 | -2.35 | -4.52 | -10.98 | -19.63 |
PEG Ratio | 0.77 | 0.11 | -0.07 | -0.04 | -0.06 | 0.25 |
PS Ratio | 3.83 | 2.75 | 22.41 | 56.57 | 10.06 | 5.22 |
PB Ratio | 24.14 | 3.54 | 4.36 | 2.22 | 1.78 | 0.99 |
P/FCF Ratio | 45.80 | -1.85 | -3.16 | -7.87 | -13.44 | -26.57 |
P/OCF Ratio | 45.60 | -1.85 | -3.18 | -7.91 | -13.84 | -27.64 |
OCF/S Ratio | 8.40 | -148.27 | -704.09 | -715.40 | -72.69 | -18.88 |
Debt / Equity Ratio | 0.38 | 5.21 | 0.20 | 0.07 | 0.06 | 0 |
Quick Ratio | 9.07 | 9.51 | 10.87 | 17.16 | 34.40 | 20.01 |
Current Ratio | 9.07 | 9.51 | 10.87 | 17.16 | 34.40 | 20.01 |
Asset Turnover | 0.64 | 0.19 | 0.04 | 0.02 | 0.10 | 0.18 |
Interest Coverage | 0.60 | -2.29 | -9.09 | -5.46 | -39.18 | n/a |
Return on Equity | -35.56% | -204.93% | -185.71% | -49.11% | -16.22% | -5.02% |
Return on Assets | -3.63% | -30.02% | -36.17% | -21.09% | -8.99% | -4.78% |
Return on Invested Capital | 14.61% | -26.11% | -39.45% | -19.65% | -9.04% | -6.01% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 98.97% | -79.49% | -671.01% | -763.21% | -55.91% | -6.70% |
Net Profit Margin | -5.64% | -159.10% | -953.66% | -1.25K% | -91.49% | -26.57% |
Pretax Profit Margin | -5.57% | -159.10% | -953.68% | -1.25K% | -91.49% | -26.57% |
Operating Profit Margin | 20.42% | -125.93% | -958.27% | -1.12K% | -89.93% | -31.84% |
FCF Margin | 8.36% | -148.66% | -708.79% | -718.88% | -74.85% | -19.63% |
EBITDA Margin | 29.52% | -101.60% | -911.70% | -1.02K% | -88.18% | -25.83% |
Add to Watchlist
Select watchlists to add or remove ANAB